Senzime AB
(OTCPK:SNZZF)
$
0.527
0 (0%)
Market Cap: 68.54 Mil
Enterprise Value: 66.06 Mil
PE Ratio: 0
PB Ratio: 2.37
GF Score: 59/100 Q2 2024 Senzime AB (publ) Earnings Call Transcript
Aug 26, 2024 / 09:00AM GMT
Release Date Price:
$0.824
(-0.12%)
Klas Palin;Commissioned;Analyst
Penser Access
()-
Hello, and welcome to Carnegie and today's presentation with Senzime and its Q2 report. My name is Klas Palin, and I'm an equity analyst. And with me in the studio, I have Philip Siberg, who is CEO of Senzime. Very welcome, Philip.
Philip Siberg
Senzime AB - Chief Executive Officer
Thank you. Nice to be here.
Klas Palin;Commissioned;Analyst
Penser Access
()-
And it would be really interesting to hear your presentation of the Q2 report. Please go ahead, Philip.
Philip Siberg
Senzime AB - Chief Executive Officer
All right. Thank you, and thank you for listening-in into this. It's both a Q2 report, but also a little bit of an update today on some of our long- and short-term guidance and what we believe in the market. So for those of you who don't know Senzime, a quick recap. We are a Sweden headquartered medical device company.
We've developed a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot